Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Banque Nationale de Belgique | BNB | May 21, 2024 | 470.00 | -1.26 |
Barco NV | BAR | May 21, 2024 | 12.96 | -1.67 |
Basilix | BAS | May 21, 2024 | 11.40 | -9.52 |
Beaulieu Av Certificates | BEAB | May 21, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | May 21, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | May 21, 2024 | 3 991.00 | -0.40 |
Belreca - Belgian Resources and Capital Company | BELR | May 21, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | May 21, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | May 21, 2024 | 0.85 | -3.41 |
Biocartis Group NV | BCART | May 21, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | May 21, 2024 | 0.02 | +7.27 |
Biotalys | BTLS | May 21, 2024 | 3.07 | -0.32 |
Boeing | BOEI | May 21, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 21, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 21, 2024 | 3.30 | -1.93 |
Brederode S.A. | BREB | May 21, 2024 | 112.60 | -0.53 |
Campine nv | CAMB | May 21, 2024 | 78.50 | +1.29 |
Candela Invest | CAND | May 21, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | May 21, 2024 | 14.90 | -0.40 |
Celyad Oncology SA | CYAD | May 21, 2024 | 0.30 | -5.50 |
Cenergy Holdings | CENER | May 21, 2024 | 8.85 | +4.12 |
Chevron | CHTEX | May 21, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 21, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 21, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 21, 2024 | 60.85 | -1.38 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 21, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 21, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 21, 2024 | 43.62 | +0.23 |
Compagnie du Bois Sauvage S.A. | COMB | May 21, 2024 | 272.00 | 0.00 |
Compagnie d`Entreprises CFE SA | CFEB | May 21, 2024 | 7.43 | -2.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.